Aktiviere Job-Benachrichtigungen per E-Mail!
Erhöhe deine Chancen auf ein Interview
Erstelle einen auf die Position zugeschnittenen Lebenslauf, um deine Erfolgsquote zu erhöhen.
Un'innovativa istituzione sanitaria offre un'opportunità unica per una Fellowship in Ricerca Clinica presso l'Istituto Oncologico del Sud della Svizzera. Questa posizione ti permetterà di sviluppare competenze cliniche nella gestione di pazienti con tumori solidi, partecipare a trial clinici di fase iniziale e collaborare con esperti del settore. Con un impegno di un anno, avrai l'opportunità di approfondire la tua conoscenza della ricerca clinica, partecipare a progetti di ricerca e pubblicare articoli su riviste peer-reviewed. Un'esperienza formativa in un ambiente stimolante e collaborativo ti attende!
The EOC, the multisite hospital of Ticino, is present with its institutions on the entire cantonal territory with a total of 1,000 beds. The organization makes it possible to effectively combine local approach and overall vision, guaranteeing the population a comprehensive and proximity hospital offer, regardless of where services are required.
Thanks to the commitment and expertise of its more than 6,500 employees and their focus on human relationships, the EOC ensures quality health care by caring for more than 41,000 patients a year and providing more than 600,000 ambulatory consultations.
To complete the team at the Oncological Institute of Southern Switzerland (IOSI) Bellinzona, New Drugs Development Unit, we are offering a
Clinical Research Fellowship (100%)
The Oncology Institute of Southern Switzerland is one of the largest clinical research centers in Switzerland. Our three main areas of clinical research comprise new drug development, lymphoproliferative diseases (lymphoma and chronic lymphocytic leukaemia), and prostate cancer. Other important areas of development in clinical research include gynecological cancer, breast, lung, skin, and gastrointestinal cancers. The IOSI has a dedicated phase 1 unit where early phase clinical trials, including first-in-human, are conducted. We have an excellent history of collaborating with both non-for-profit academic organizations and the pharmaceutical industry. Of particular relevance are our collaborations with the Institute of Oncology Research (IOR), the Institute of Biochemical Research (IRB), and the Swiss Group for Clinical Cancer Research (SAKK). We have a central role in the Faculty of Biomedical Sciences of the Università della Svizzera Italiana (USI). We are offering a Clinical Research fellowship in Drug Development in solid tumors starting from January 2026. This fellowship would incorporate activities in the phase 1 Unit of the IOSI and clinical activity. During the fellowship program, there will be the possibility to participate in educational activities performed in our institute and selected external events. Through this fellowship, you will develop your clinical skills, increase your knowledge on how to conduct clinical research, and manage patients enrolled in clinical trials, particularly focusing on early phase clinical trials. A minimum commitment of one year is required to allow you to complete the fellowship objectives.
Job Summary / Objectives:
Salary:
The per annum rate is approximately 40,000 CHF; the Swiss mandatory health insurance costs will be deducted from this before payment to the post holder. Candidates receiving a grant from their institution or from a national or international society will instead have their grant topped up to this level. Travel and accommodation costs are considered as included in this salary, and there will be no additional payments made.
Eligibility:
You should also verify your eligibility for registering with (MEBEKO). However, we recommend you do not apply to register with MEBEKO at this point.